Study to evaluate the effect of individualized homeopathic medicines compared with a placebo in treating adults with early-stage (Stage I) high blood pressure.

Efficacy of Individualized Homoeopathic Medicines In The Treatment Of Stage-I Essential Hypertension In Adults : A Double Blind, Randomized, Placebo_ Controlled Trial - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096707

Enrollment

120

Registered

2025-10-31

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Individualized Homoeopathic medicines: According homoeopathic similimum, single medicine are given in potency as per the required based on homoeopathic principles as per organon of medi

Eligibility

Inclusion criteria

Inclusion criteria: 1. Systolic Blood Pressure from (140-159) mm of Hg and Diastolic Blood Pressure from (90-99) mm of Hg. 2. Patients who have not taken any anti-hypertensive treatment. 3.Patient who can give their informed consent willingly for study and comply for regular follow up.

Exclusion criteria

Exclusion criteria: 1. Patient who had suffeing from secondary hypertension . 2.Patients suffering from any terminal illness like uncontrolled diabetes mellitus, chronic kidney disease, diagnosed autoimmune gastritis with hyperhomocysteinaemia, who have known heart disease like history of MI, coronary artery disease, history of cardio- vascular accident etc. 3.Pregnant women and lactating mother and 4.Person who had history of drug/alcohol abuse.

Design outcomes

Primary

Measure	Time frame
To detect the group difference between individualized homoeopathic medicines and identical looking placebo in systolic blood pressure (SBP) and diastolic blood pressure (DBP) in essential hypertension stage-I.Timepoint: After 3 months of intervention	—

Secondary

Measure	Time frame
1.To detect the group differences of individuals becoming normotensive from stage-I essential hypertension. 2.To detect the group differences of biochemical parameters i.e., serum lipid profile, liver function test, serum urea and creatinine, serum TSH, serum FBS and PPBS. 3.To detect the group differences in Measure Yourself Outcome Profile-2 (MYMOP-2), health related quality of life.Timepoint: after 3 months of intervention.	—

Measure

Time frame

1.To detect the group differences of individuals becoming normotensive from stage-I essential hypertension. 2.To detect the group differences of biochemical parameters i.e., serum lipid profile, liver function test, serum urea and creatinine, serum TSH, serum FBS and PPBS. 3.To detect the group differences in Measure Yourself Outcome Profile-2 (MYMOP-2), health related quality of life.Timepoint: after 3 months of intervention.

—

Countries

India

Contacts

Public ContactProfDr Saptarshi Choudhury

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital

drcsaptarshi@gmail.com9836080877

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026